Find your path to Nicholas
182 people in our graph share verified history with Nicholas — schools, employers, funds. One of them is your warm intro.
Aniq KassamunlockedNicholas: together at Medici Therapeutics (2023–2026)
Nicholas: together at Medici Therapeutics
×2Nicholas: together at Memorial Sloan Kettering Cancer Center
×8Nicholas: together at National Institutes of Health
Executive at Lyell
Intro paths
→
In turn, Nicholas can intro founders to Lyell's investors below.
Lyell's investors · 5
Co-founders at Lyell
SR
Stan RiddellExecutive Officer
RK
Richard KlausnerExecutive Officer, Director, Promoter
Experience
- Medici TherapeuticsCo-founder, Chief Medical Officercurrent2023 — presentBoston & San Francisco
- RestifoPartners, LLCBiotech Analyst, Strategist and Explorercurrent2022 — presentChevy Chase, Maryland, United States
- RestifoPartners, LLCFounder and CEO Restifo Partners2022 — 2025Chevy Chase, Maryland, United States
- The National Institutes of HealthAdvisor: Cancer Data Science Laboratorycurrent2022 — presentBethesda, MD
- Lyell ImmunopharmaExecutive Vice President, Research2019 — 2022South San Francisco, California, United States
- National Institutes of HealthIndependently Tenured Principal Investigator1989 — 2019Bethesda, Maryland, United States
- Memorial Sloan Kettering Cancer CenterPostdoctoral Fellow1988 — 1989New York, NY
Skills & more
Post-thymic T cell maturation1Molecular pathways of T cell maturation, exhaustion, and fate1
- MD, Previously licensed to practice Medicine and Surgery in New York and Maryland before turning to research full-time — New York State License No: 175094; Maryland Board of Physicians License Number: D40800
- M.D. — NEW YORK UNIVERSITY LANGONE MEDICAL CENTER
From Nicholas's professional profile.
Frequently asked questions
- Who is Nicholas Restifo?
- Executive Officer at Lyell
- Where does Nicholas Restifo work?
- Nicholas Restifo is Executive at Lyell.
- Where did Nicholas Restifo go to school?
- Nicholas Restifo studied at National Cancer Institute (NCI), Bethesda (Principal Investigator, Cancer Immunotherapy); Memorial Sloan Kettering Cancer Center (Postdoctoral Work, Surgical Research).
Same school
Also attended Memorial Sloan Kettering Cancer Center7
Jakob DupontExecutive Partner, Private Equity at Sofinnova VenturesKevin DaiManaging Director at Vivo CapitalSteven SoignetGeneral Partner at Arcus VenturesDavid FeltquateAdvisor at RA CapitalJustin BekelmanExecutive Officer, Director at Daymark HealthClifford SolomonExecutive Officer, Director at Gibson Oncology
+ 1 more
Shared employers
Also worked at Medici Therapeutics2
Also worked at The National Institutes of Health121
Jun JeonInvestor at Khosla VenturesUri LopatinInvestor at Khosla VenturesMax ColbertPhysician-Entrepreneur at Medical Excellence CapitalVictoria GraceFounding partner of Colle Capital Partners, an opportunistic early-stage technology venture fundAshok SrinivasanChief Science Advisor at AIFPallavi AbrahamInvestor at SUPPLY CHANGE CAPITAL
+ 115 more
Also worked at Lyell Immunopharma10
Cathy FriedmanInvestor at GV (Google Ventures)Matthew BickExecutive Officer, Director, Promoter at Accipiter BiosciencesMarc LajoieCo-founder & Chief Executive Officer at Outpace BioScott BoykenCo-founder & Chief Technology Officer at Outpace BioBlythe SatherExecutive Officer at Tune TherapeuticsSumant RamachandraChief Executive Officer and Board Director at Lutris Pharma
+ 4 more
Also worked at Memorial Sloan Kettering Cancer Center70
Neil NagVenture Partner at Moment Ventures, LlcBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalTarek El-SawyVenture Partner at RaivenStella PaffenholzSenior Associate at Atlas VentureMaurizio FazioPrincipal at Atlas VentureAlley (Welsh) OlshanskyAdvisor at Casdin Capital
+ 64 more































